We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
SOFW.TA

Price
1426.00
Stock movement up
+78.00 (5.79%)
Company name
Sofwave Medical Ltd
Exchange
(TA
,
Currency
ILA
)
Sector
Healthcare >
Medical Devices
Market cap
49.09B
Ent value
49.08B
Price/Sales
1764.11
Price/Book
1959.99
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-24.47%
3 year return
-14.99%
5 year return
-
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

SOFW.TA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1764.11
Price to Book1959.99
EV to Sales1763.89

FINANCIALS

Per share

Loading...
Per share data
Current share count34.42M
EPS (TTM)-0.07
FCF per share (TTM)-0.09

Income statement

Loading...
Income statement data
Revenue (TTM)27.83M
Gross profit (TTM)21.06M
Operating income (TTM)-2.17M
Net income (TTM)-2.51M
EPS (TTM)-0.07
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)75.69%
Operating margin (TTM)-7.80%
Profit margin (TTM)-9.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash21.08M
Net receivables7.74M
Total current assets35.74M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment3.96M
Total assets39.98M
Accounts payable5.66M
Short/Current long term debt0.00
Total current liabilities14.26M
Total liabilities14.94M
Shareholder's equity25.05M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-2.92M
Capital expenditures (TTM)177.00K
Free cash flow (TTM)-3.10M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-10.03%
Return on Assets-6.28%
Return on Invested Capital-10.03%
Cash Return on Invested Capital-12.36%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1379.00
Daily high1447.00
Daily low1379.00
Daily Volume16K
All-time high3685.00
1y analyst estimate-
Beta0.54
EPS (TTM)-0.07
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
SOFW.TAS&P500
Current price drop from All-time high-61.30%-14.41%
Highest price drop-80.98%-56.47%
Date of highest drop6 Jun 20239 Mar 2009
Avg drop from high-53.17%-11.07%
Avg time to new high80 days12 days
Max time to new high872 days1805 days
COMPANY DETAILS
SOFW.TA (Sofwave Medical Ltd) company logo
Marketcap
49.09B
Marketcap category
Large-cap
Description
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of an ultrasound technology for treating fine lines and wrinkles in Israel and internationally. It offers non-invasive skin treatment aesthetic medical devices to physicians under the Softwave brand name. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
Employees
117
Investor relations
-
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
SAN CLEMENTE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced t...
March 26, 2025
– Fourth quarter revenue of $18.3M, +20% year-over-year growth; IFRS gross margin of 77.0% – Full fiscal 2024 revenue of $59.7M, +19% year-over-year growth; IFRS gross margin of 76.0% – Full fiscal 20...
March 5, 2025
SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, report...
January 13, 2025
— Third quarter revenue of $13.5M, +10.5% year-over-year growth; IFRS gross margin of 75.2%— Third quarter pulse recurring revenue of $5.4M, +72% year-over-year growth— First nine months revenue of $4...
November 13, 2024
SAN CLEMENTE, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced th...
November 4, 2024
Abstract entitled, “Safety and Efficacy of Synchronous Ultrasound Parallel Beam Technology to Lift the Upper Lip and Improve Perioral Rhytids” selected as the highest rated Cosmetic Dermatologic Surge...
October 22, 2024
SAN CLEMENTE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced th...
October 7, 2024
SAN CLEMENTE, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced t...
September 25, 2024
SAN CLEMENTE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced t...
September 4, 2024
Latest Pure Impact™ indication expansion includes strengthening and improvement in muscle tone and firmness of the armsRepresents next major step toward Pure Impact™ covering multiple body areas and m...
August 12, 2024
Next page